Optimization of therapy for severe aplastic anemia based on clinical, biologic, and treatment response parameters: conclusions of an international working group on severe aplastic anemia convened by the Blood and Marrow Transplant Clinical Trials Network, March 2010.
Pulsipher
Michael A
MA
Primary Children's Medical Center, University of Utah School of Medicine, Salt Lake City, Utah 84113, USA. michael.pulsipher@hsc.utah.edu
Young
Neal S
NS
Tolar
Jakub
J
Risitano
Antonio M
AM
Deeg
H Joachim
HJ
Anderlini
Paolo
P
Calado
Rodrigo
R
Kojima
Seiji
S
Eapen
Mary
M
Harris
Richard
R
Scheinberg
Phillip
P
Savage
Sharon
S
Maciejewski
Jaroslaw P
JP
Tiu
Ramon V
RV
DiFronzo
Nancy
N
Horowitz
Mary M
MM
Antin
Joseph H
JH
D000375:Aging; D000741:Anemia, Aplastic / Q000503:physiopathology / Q000628:therapy*; D018070:Biological Specimen Banks; D035843:Biomedical Research / Q000458:organization & administration; D016026:Bone Marrow Transplantation / Q000009:adverse effects / Q000379:methods; D002986:Clinical Trials as Topic; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D038622:Internationality; D009656:North America; D055818:Public-Private Sector Partnerships; D012042:Registries